Amgen Inc. buy Royal Bank of Canada
Start price
27.11.24
/
50%
€265.15
Target price
27.11.25
€311.78
Performance (%)
10.73%
End price
28.11.25
€293.60
Summary
This prediction ended on 28.11.25 with a price of €293.60. The BUY prediction by Royal_Bank_of_Canada finished with a performance of 10.73%. Royal_Bank_of_Canada has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. Dividends of €9.41 are taken into consideration when calculating the performance. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | -3.105% | -3.105% | 8.025% |
| iShares Core DAX® | -6,02 % | -4,60 % | 1,27 % |
| iShares Nasdaq 100 | 0,51 % | 0,16 % | 14,57 % |
| iShares Nikkei 225® | -7,16 % | -2,21 % | 28,11 % |
| iShares S&P 500 | -0,26 % | -0,84 % | 10,20 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at Royal Bank of Canada from $360.00 to $330.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten